Download presentation
Presentation is loading. Please wait.
1
RIPK3 Slams the Brake on Leukemogenesis
Francis Ka-Ming Chan Cancer Cell Volume 30, Issue 1, Pages 7-9 (July 2016) DOI: /j.ccell Copyright © 2016 Elsevier Inc. Terms and Conditions
2
Figure 1 RIPK3 and MLKL Mediate Cell Death and IL-1β Processing to Limit the Extent of FLT3-ITD-Induced Leukemogenesis In human AML, loss of RIPK3 and MLKL inhibit these processes, which results in a developmental block and enhanced survival of transformed immature progenitors. Cancer Cell , 7-9DOI: ( /j.ccell ) Copyright © 2016 Elsevier Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.